New Risk • Aug 15
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 41% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.5% net profit margin). Market cap is less than US$100m (₩29.6b market cap, or US$20.9m). Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₩5,290, the stock trades at a trailing P/E ratio of 3.8x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 46% over the past three years. Anuncio • Aug 04
Hanchang Ind.Co.,Ltd (KOSDAQ:A079170) announces an Equity Buyback for KRW 1,500 million worth of its shares. Hanchang Ind.Co.,Ltd (KOSDAQ:A079170) announces a share repurchase program. Under the program, the company will repurchase up to KRW 1,500 million worth of its shares pursuant to an agreement with Mirae Asset Securities. The purpose of the program is to stabilize stock prices, enhance shareholder value and employee compensation. The program will expire on February 3, 2027. As of August 2, 2026, the company had 30,153 shares in treasury and 0 shares in treasury through other acquisition. Valuation Update With 7 Day Price Move • Jun 24
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩4,475, the stock trades at a trailing P/E ratio of 3.2x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 63% over the past three years. Buy Or Sell Opportunity • Jun 08
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 22% to ₩5,020. The fair value is estimated to be ₩6,332, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has grown by 31%. Anuncio • Feb 13
Hanchang Ind.Co.,Ltd, Annual General Meeting, Mar 27, 2026 Hanchang Ind.Co.,Ltd, Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 227-14, amsogogae-ro, yanggam-myeon, gyeonggi-do, hwaseong South Korea Upcoming Dividend • Dec 22
Upcoming dividend of ₩220 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 17 April 2026. Trailing yield: 3.3%. Lower than top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.3%). Reported Earnings • Nov 16
Third quarter 2025 earnings released Third quarter 2025 results: Revenue: ₩21.3b (up 16% from 3Q 2024). Net income: ₩275.1m (up 22% from 3Q 2024). Profit margin: 1.3% (in line with 3Q 2024). Anuncio • Nov 07
Hanchang Ind.Co.,Ltd announces Annual dividend, payable on April 17, 2026 Hanchang Ind.Co.,Ltd announced Annual dividend of KRW 220.0000 per share payable on April 17, 2026, ex-date on December 29, 2025 and record date on December 31, 2025. Buy Or Sell Opportunity • Jul 14
Now 21% undervalued Over the last 90 days, the stock has risen 17% to ₩7,910. The fair value is estimated to be ₩9,985, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 5.4%. New Risk • Jun 28
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 306% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. This is currently the only risk that has been identified for the company. Buy Or Sell Opportunity • Jun 21
Now 20% undervalued Over the last 90 days, the stock has risen 11% to ₩7,970. The fair value is estimated to be ₩9,965, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 5.4%. Valuation Update With 7 Day Price Move • Jun 17
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩8,350, the stock trades at a trailing P/E ratio of 6.1x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 15% over the past three years. Anuncio • Feb 13
Hanchang Ind.Co.,Ltd, Annual General Meeting, Mar 28, 2025 Hanchang Ind.Co.,Ltd, Annual General Meeting, Mar 28, 2025, at 09:01 Tokyo Standard Time. Location: conference room, 227-14, amsogogae-ro, yanggam-myeon, gyeonggi-do, hwaseong South Korea Upcoming Dividend • Dec 20
Upcoming dividend of ₩160 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 16 April 2025. Trailing yield: 2.4%. Lower than top quartile of South Korean dividend payers (3.9%). In line with average of industry peers (2.2%). Reported Earnings • Nov 20
Third quarter 2024 earnings released: EPS: ₩44.00 (vs ₩15.00 in 3Q 2023) Third quarter 2024 results: EPS: ₩44.00 (up from ₩15.00 in 3Q 2023). Revenue: ₩18.4b (up 8.8% from 3Q 2023). Net income: ₩225.9m (up 198% from 3Q 2023). Profit margin: 1.2% (up from 0.4% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Nov 12
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩7,310, the stock trades at a trailing P/E ratio of 5.2x. Average trailing P/E is 10x in the Chemicals industry in South Korea. Total loss to shareholders of 11% over the past three years. Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩5,710, the stock trades at a trailing P/E ratio of 12.3x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 42% over the past three years. Upcoming Dividend • Dec 20
Inaugural dividend of ₩200 per share Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 17 April 2024. This is the first dividend for Hanchang Ind.Co.Ltd since going public. The average dividend yield among industry peers is 1.8%. New Risk • Nov 26
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.6% Last year net profit margin: 6.5% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risks Profit margins are more than 30% lower than last year (1.6% net profit margin). Market cap is less than US$100m (₩43.3b market cap, or US$33.2m). Valuation Update With 7 Day Price Move • Oct 18
Investor sentiment improves as stock rises 45% After last week's 45% share price gain to ₩12,780, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 65% over the past three years. Valuation Update With 7 Day Price Move • Aug 22
Investor sentiment improves as stock rises 25% After last week's 25% share price gain to ₩12,950, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 140% over the past three years. Valuation Update With 7 Day Price Move • Jul 06
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩14,300, the stock trades at a trailing P/E ratio of 13.7x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 187% over the past three years. Valuation Update With 7 Day Price Move • Jun 14
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩16,080, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 231% over the past three years. Valuation Update With 7 Day Price Move • May 17
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩13,350, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 179% over the past three years. Valuation Update With 7 Day Price Move • May 03
Investor sentiment improves as stock rises 34% After last week's 34% share price gain to ₩18,050, the stock trades at a trailing P/E ratio of 15.3x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 277% over the past three years. Valuation Update With 7 Day Price Move • Apr 17
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩12,510, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 183% over the past three years. Upcoming Dividend • Dec 21
Inaugural dividend of ₩190 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. This is the first dividend for Hanchang Ind.Co.Ltd since going public. The average dividend yield among industry peers is 2.4%. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Oct 13
Investor sentiment deteriorated over the past week After last week's 22% share price decline to ₩9,550, the stock trades at a trailing P/E ratio of 11.6x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 74% over the past three years. Valuation Update With 7 Day Price Move • Sep 29
Investor sentiment improved over the past week After last week's 35% share price gain to ₩12,600, the stock trades at a trailing P/E ratio of 15.3x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 135% over the past three years. Valuation Update With 7 Day Price Move • Jul 22
Investor sentiment improved over the past week After last week's 19% share price gain to ₩9,090, the stock trades at a trailing P/E ratio of 12.5x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 74% over the past three years. Valuation Update With 7 Day Price Move • Jun 15
Investor sentiment deteriorated over the past week After last week's 19% share price decline to ₩7,790, the stock trades at a trailing P/E ratio of 10.7x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 38% over the past three years. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Upcoming Dividend • Dec 22
Upcoming dividend of ₩120 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 15 April 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 1.5%. Lower than top quartile of South Korean dividend payers (2.4%). In line with average of industry peers (1.5%). Valuation Update With 7 Day Price Move • Jul 30
Investor sentiment deteriorated over the past week After last week's 23% share price decline to ₩11,650, the stock trades at a trailing P/E ratio of 40.7x. Average trailing P/E is 21x in the Chemicals industry in South Korea. Total returns to shareholders of 86% over the past three years. Valuation Update With 7 Day Price Move • Jul 15
Investor sentiment improved over the past week After last week's 38% share price gain to ₩16,300, the stock trades at a trailing P/E ratio of 56.9x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 161% over the past three years. Valuation Update With 7 Day Price Move • Jun 30
Investor sentiment improved over the past week After last week's 27% share price gain to ₩12,350, the stock trades at a trailing P/E ratio of 43.1x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 96% over the past three years. Is New 90 Day High Low • Feb 24
New 90-day low: ₩7,050 The company is down 12% from its price of ₩8,000 on 26 November 2020. The South Korean market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period. Anuncio • Feb 10
Hanchang Ind.Co.,Ltd, Annual General Meeting, Mar 26, 2021 Hanchang Ind.Co.,Ltd, Annual General Meeting, Mar 26, 2021, at 09:00 Korea Standard Time. Upcoming Dividend • Dec 22
Upcoming Dividend of ₩110 Per Share Will be paid on the 14th of April to those who are registered shareholders by the 29th of December. The company last paid an ordinary dividend in March 2010. The average dividend yield among industry peers is 0.9%. Valuation Update With 7 Day Price Move • Oct 20
Market pulls back on stock over the past week After last week's 15% share price decline to ₩8,190, the stock is trading at a trailing P/E ratio of 34.3x, down from the previous P/E ratio of 40.4x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 13%. Is New 90 Day High Low • Oct 06
New 90-day high: ₩7,780 The company is up 49% from its price of ₩5,210 on 08 July 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 30% over the same period.